Author:
Logue J.P.,Magee B.,Hunter R.D.,Murdoch R.D.
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference9 articles.
1. The antiemetic potential of the 5-hydroxytryptamine-3 receptor antagonist BRL 43694;Bermudez;British Journal of Cancer,1988
2. The serotonin type-3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin;Carmichael;British Medical Journal,1988
3. A pharmacokinetic study of granisetron (BRL43694). A selective 5-HT3 receptor antagonist: correlation with antiemetic;Carmichael;Cancer Chemotherapy Pharmacology,1989
4. Randomized clinical trial of Levonantradol and Chlorpromazine in the prevention of radiotherapy-induced vomiting;Lucraft;Clinical Radiology,1982
5. A comparative study of the use of Granisetron, a selective 5-HT3 antagonist, versus a standard antiemetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced induced emesis;Marty;European Journal of Cancer,1990
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献